A study to evaluate the safety, tolerability and absorption to the blood after administration of single and multiple doses of AZD8154 in healthy participants.

Trial Identifier: D8900C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL International GmbH
NCTID:: NCT03436316
Start Date: July 2018
Primary Completion Date: July 2019
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050